Tessa Romero
Stock Analyst at JP Morgan
(1.64)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BHVN Biohaven | Maintains: Overweight | 68 55 | 14.07 | 290.9% | 7 | Jun 18, 2025 | |
CYTK Cytokinetics | Maintains: Overweight | 71 53 | 33.16 | 59.83% | 5 | Jun 9, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Overweight | 26 30 | 22.09 | 35.81% | 7 | Jun 6, 2025 | |
LXEO Lexeo Therapeutics | Maintains: Overweight | 16 10 | 4.12 | 142.72% | 2 | May 30, 2025 | |
DYN Dyne Therapeutics | Maintains: Neutral | 18 17 | 9.59 | 77.27% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 38 | 10.94 | 247.35% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 18 15 | 0.77 | 1848.05% | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 31 | 35.76 | -13.31% | 5 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 32 29 | 9.65 | 200.52% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 31 | 13.2 | 134.85% | 8 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 46 | 33.52 | 37.23% | 6 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 8 7 | 4.74 | 47.68% | 5 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 54 55 | 32.37 | 69.91% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 39 36 | n/a | n/a | 4 | Jun 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 140 150 | n/a | n/a | 1 | Mar 2, 2021 |